Nigeria vs Papua New Guinea: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Nigeria
35.0%
in 2025
Papua New Guinea
28.0%
in 2025
Nigeria rank
188th
Papua New Guinea rank
190th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Nigeria
- Papua New Guinea
How they compare
Nigeria currently reports 35.0% against 28.0% in Papua New Guinea, a difference of 7.0%.
That makes Nigeria's figure about 1.2 times Papua New Guinea's.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Papua New Guinea ahead.
Nigeria ranks 188th and Papua New Guinea ranks 190th of 194 countries.
Across the 3 decades both report, Nigeria averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Nigeria | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.9% | 2.0% | 1.1% | Papua New Guinea |
| 2020s | 28.7% | 27.8% | 0.8% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Nigeria or Papua New Guinea?
- Nigeria, at 35.0% against 28.0% in Papua New Guinea as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Nigeria and Papua New Guinea?
- 7.0%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Papua New Guinea?
- 26 years are reported by both, from 2000 to 2025.
- How do Nigeria and Papua New Guinea rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Nigeria ranks 188th and Papua New Guinea ranks 190th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.